• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata.高通量 T 细胞受体测序鉴定斑秃中克隆扩增的 CD8+ T 细胞群体。
JCI Insight. 2018 Oct 4;3(19):121949. doi: 10.1172/jci.insight.121949.
2
Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata.选择性抑制 JAK3 信号传导足以逆转斑秃。
JCI Insight. 2021 Apr 8;6(7):142205. doi: 10.1172/jci.insight.142205.
3
Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata).在自身免疫性脱发(斑秃)小鼠模型中,P物质作为一种免疫调节性神经肽。
J Invest Dermatol. 2007 Jun;127(6):1489-97. doi: 10.1038/sj.jid.5700704. Epub 2007 Feb 1.
4
Interferon-gamma-deficient mice are resistant to the development of alopecia areata.γ-干扰素缺陷小鼠对斑秃的发展具有抗性。
Br J Dermatol. 2006 Sep;155(3):515-21. doi: 10.1111/j.1365-2133.2006.07377.x.
5
Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.斑秃:动物模型揭示自身免疫发病机制及新型免疫治疗策略。
Autoimmun Rev. 2016 Jul;15(7):726-35. doi: 10.1016/j.autrev.2016.03.008. Epub 2016 Mar 10.
6
SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.细胞因子信号转导抑制因子3(SOCS3)治疗通过抑制CD8 + T细胞介导的自身免疫性破坏来预防斑秃的发生。
Oncotarget. 2017 May 16;8(20):33432-33443. doi: 10.18632/oncotarget.16504.
7
Pro-inflammatory Vδ1T-cells infiltrates are present in and around the hair bulbs of non-lesional and lesional alopecia areata hair follicles.促炎 Vδ1T 细胞浸润存在于非损伤和损伤的斑秃毛囊的毛囊球及其周围。
J Dermatol Sci. 2020 Nov;100(2):129-138. doi: 10.1016/j.jdermsci.2020.09.001. Epub 2020 Sep 18.
8
Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice.CD4+和CD8+ T淋巴细胞之间的合作介导斑秃:移植到Prkdc(scid)小鼠的人头皮外植体上。
Arch Dermatol. 2002 Jul;138(7):916-22. doi: 10.1001/archderm.138.7.916.
9
Toward the Clonotype Analysis of Alopecia Areata-Specific, Intralesional Human CD8+ T Lymphocytes.斑秃特异性皮损内人类CD8 + T淋巴细胞的克隆型分析
J Investig Dermatol Symp Proc. 2015 Nov;17(2):9-12. doi: 10.1038/jidsymp.2015.31.
10
Altered T cell subpopulations and serum anti-TYRP2 and tyrosinase antibodies in the acute and chronic phase of alopecia areata in the C3H/HeJ mouse model.斑秃 C3H/HeJ 小鼠模型急性和慢性期 T 细胞亚群改变及血清抗 TYRP2 和酪氨酸酶抗体。
J Dermatol Sci. 2021 Oct;104(1):21-29. doi: 10.1016/j.jdermsci.2021.09.001. Epub 2021 Sep 3.

引用本文的文献

1
Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced alopecia areata.硫化钠诱导的斑秃小鼠模型中离子组学特征与代谢异常之间的关联
Front Pharmacol. 2025 May 14;16:1507348. doi: 10.3389/fphar.2025.1507348. eCollection 2025.
2
Immune Memory: A New Frontier in Treating Recurrent Inflammatory Skin Diseases.免疫记忆:治疗复发性炎症性皮肤病的新前沿。
Clin Rev Allergy Immunol. 2025 Mar 18;68(1):31. doi: 10.1007/s12016-025-09039-0.
3
Immune Repertoires in Various Dermatologic and Autoimmune Diseases.各种皮肤病和自身免疫性疾病中的免疫组库
Genes (Basel). 2024 Dec 11;15(12):1591. doi: 10.3390/genes15121591.
4
Deciphering the Complex Immunopathogenesis of Alopecia Areata.解析斑秃的复杂免疫发病机制。
Int J Mol Sci. 2024 May 22;25(11):5652. doi: 10.3390/ijms25115652.
5
Inhibition of T-cell activity in alopecia areata: recent developments and new directions.斑秃中 T 细胞活性的抑制:最新进展和新方向。
Front Immunol. 2023 Nov 6;14:1243556. doi: 10.3389/fimmu.2023.1243556. eCollection 2023.
6
Genome-Wide Association Study of Alopecia Areata in Taiwan: The Conflict Between Individuals and Hair Follicles.台湾斑秃的全基因组关联研究:个体与毛囊之间的冲突
Clin Cosmet Investig Dermatol. 2023 Sep 21;16:2597-2612. doi: 10.2147/CCID.S428788. eCollection 2023.
7
Which is the Ideal JAK Inhibitor for Alopecia Areata - Baricitinib, Tofacitinib, Ritlecitinib or Ifidancitinib - Revisiting the Immunomechanisms of the JAK Pathway.斑秃的理想JAK抑制剂是哪一种——巴瑞替尼、托法替布、利特昔替尼还是依非替尼——重新审视JAK通路的免疫机制。
Indian Dermatol Online J. 2023 Jun 28;14(4):465-474. doi: 10.4103/idoj.idoj_452_22. eCollection 2023 Jul-Aug.
8
Functional interrogation of lymphocyte subsets in alopecia areata using single-cell RNA sequencing.单细胞 RNA 测序技术在斑秃中对淋巴细胞亚群的功能研究。
Proc Natl Acad Sci U S A. 2023 Jul 18;120(29):e2305764120. doi: 10.1073/pnas.2305764120. Epub 2023 Jul 10.
9
Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.针对克隆性 T 细胞疾病的 T 细胞受体可变区的患者特异性靶向作为一种治疗策略。
Clin Cancer Res. 2023 Oct 13;29(20):4230-4241. doi: 10.1158/1078-0432.CCR-22-0906.
10
Functional heterogeneity of human skin-resident memory T cells in health and disease.人类皮肤驻留记忆 T 细胞在健康和疾病中的功能异质性。
Immunol Rev. 2023 Jul;316(1):104-119. doi: 10.1111/imr.13213. Epub 2023 May 5.

本文引用的文献

1
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis.一项开放性标签试验,旨在评估托法替尼治疗中度至重度斑状型斑秃、全秃和普秃的疗效。
J Invest Dermatol. 2018 Jul;138(7):1539-1545. doi: 10.1016/j.jid.2018.01.032. Epub 2018 Feb 13.
2
Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing αβ T cell clones.临床缓解的银屑病皮损含有银屑病特异性产生白细胞介素-17的αβ T细胞克隆。
J Clin Invest. 2017 Nov 1;127(11):4031-4041. doi: 10.1172/JCI93396. Epub 2017 Sep 25.
3
Treatment of Alopecia Areata With Tofacitinib.他卡西醇治疗斑秃。
JAMA Dermatol. 2017 Jun 1;153(6):600-602. doi: 10.1001/jamadermatol.2017.0001.
4
Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes.1 型糖尿病中 T 细胞和 B 细胞受体库的组织分布和克隆多样性。
JCI Insight. 2016 Dec 8;1(20):e88242. doi: 10.1172/jci.insight.88242.
5
Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients.托法替尼治疗严重斑秃及其变异型:90 例患者研究。
J Am Acad Dermatol. 2017 Jan;76(1):22-28. doi: 10.1016/j.jaad.2016.09.007. Epub 2016 Nov 2.
6
Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata.托法替尼枸橼酸盐治疗斑秃患者的安全性和疗效。
JCI Insight. 2016 Sep 22;1(15):e89776. doi: 10.1172/jci.insight.89776.
7
Molecular signatures define alopecia areata subtypes and transcriptional biomarkers.分子特征定义斑秃亚型和转录生物标志物。
EBioMedicine. 2016 May;7:240-7. doi: 10.1016/j.ebiom.2016.03.036. Epub 2016 Mar 31.
8
Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers.用托法替布治疗斑秃患者可导致毛发再生以及血清和皮肤生物标志物的变化。
Exp Dermatol. 2016 Aug;25(8):642-3. doi: 10.1111/exd.13060.
9
Identification of Autoantigen Epitopes in Alopecia Areata.斑秃中自身抗原表位的鉴定
J Invest Dermatol. 2016 Aug;136(8):1617-1626. doi: 10.1016/j.jid.2016.04.004. Epub 2016 Apr 16.
10
The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.托法替布——一种用于治疗类风湿性关节炎的口服Janus激酶抑制剂的作用机制。
Clin Exp Rheumatol. 2016 Mar-Apr;34(2):318-28. Epub 2016 Mar 10.

高通量 T 细胞受体测序鉴定斑秃中克隆扩增的 CD8+ T 细胞群体。

High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata.

机构信息

Department of Dermatology and.

Department of Pathology, Columbia University, New York, New York, USA.

出版信息

JCI Insight. 2018 Oct 4;3(19):121949. doi: 10.1172/jci.insight.121949.

DOI:10.1172/jci.insight.121949
PMID:30282836
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6237451/
Abstract

Alopecia areata (AA) is an autoimmune disease in which cytotoxic T cells specifically target growing hair follicles. We used high-throughput TCR sequencing in the C3H/HeJ mouse model of AA and in human AA patients to gain insight into pathogenic T cell populations and their dynamics, which revealed clonal CD8+ T cell expansions in lesional skin. In the C3H/HeJ model, we observed interindividual sharing of TCRβ chain protein sequences, which strongly supports a model of antigenic drive in AA. The overlap between the lesional TCR repertoire and a population of CD8+NKG2D+ T cells in skin-draining lymph nodes identified this subset as pathogenic effectors. In AA patients, treatment with the oral JAK inhibitor tofacitinib resulted in a decrease in clonally expanded CD8+ T cells in the scalp but also revealed that many expanded lesional T cell clones do not completely disappear from either skin or blood during treatment with tofacitinib, which may explain in part the relapse of disease after stopping treatment.

摘要

斑秃(AA)是一种自身免疫性疾病,其中细胞毒性 T 细胞特异性靶向生长中的毛囊。我们使用 C3H/HeJ 小鼠 AA 模型和人类 AA 患者的高通量 TCR 测序,深入了解致病 T 细胞群体及其动态,这揭示了病变皮肤中克隆性 CD8+T 细胞的扩增。在 C3H/HeJ 模型中,我们观察到 TCRβ链蛋白序列的个体间共享,这强烈支持 AA 中的抗原驱动模型。病变 TCR 库与皮肤引流淋巴结中一群 CD8+NKG2D+T 细胞的重叠将该亚群鉴定为致病性效应物。在 AA 患者中,口服 JAK 抑制剂托法替尼治疗导致头皮中克隆性扩增的 CD8+T 细胞减少,但也表明在托法替尼治疗期间,许多扩增的病变 T 细胞克隆并没有完全从皮肤或血液中消失,这部分解释了治疗停止后疾病的复发。